Verona Pharma plc
PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE

Abstract:

The present invention relates to a dry powder pharmaceutical composition suitable for administration by inhalation comprising: (i) ensifentrine particles; (ii) coarse lactose particles having a Dv50 of from 40 .mu.m to 80 .mu.m; and (iii) fine lactose particles having a Dv50 of from 5 .mu.m to 10 .mu.m, wherein: the fine lactose particles are present in an amount of from 0.1 wt % to 6.0 wt % relative to the total weight to the dry powder pharmaceutical composition. Also provided is a dry powder inhaler comprising the dry powder pharmaceutical composition and medical use of the dry powder pharmaceutical composition.